Llovet JM, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med, 359, 378-390 (2008)
Cheng AL, et al : Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma :a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol, 10, 25-34 (2009)